BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21763565)

  • 1. Atenolol: a promising alternative to propranolol for the treatment of hemangiomas.
    Raphaël MF; de Graaf M; Breugem CC; Pasmans SGMA; Breur JMPJ
    J Am Acad Dermatol; 2011 Aug; 65(2):420-421. PubMed ID: 21763565
    [No Abstract]   [Full Text] [Related]  

  • 2. Atenolol treatment for severe infantile hemangiomas: comparison with a propranolol group of our centre.
    Dakoutrou M; Alexopoulos A; Miligkos M; Georgiadou E; Kanaka-Gantenbein C; Kakourou T
    J Eur Acad Dermatol Venereol; 2019 May; 33(5):e199-e200. PubMed ID: 30707776
    [No Abstract]   [Full Text] [Related]  

  • 3. Atenolol as an alternative to propranolol for the management of sleep disturbances in the treatment of infantile hemangiomas.
    Gumina ME; Yan AC
    Pediatr Dermatol; 2019 Jul; 36(4):556-557. PubMed ID: 30983047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study.
    Ábarzúa-Araya A; Navarrete-Dechent CP; Heusser F; Retamal J; Zegpi-Trueba MS
    J Am Acad Dermatol; 2014 Jun; 70(6):1045-9. PubMed ID: 24656727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac arrest in a toddler treated with propranolol for infantile Hemangioma: a case report.
    Tosoni A; Cutrone M; Dalle Carbonare M; Pettenazzo A; Perilongo G; Sartori S
    Ital J Pediatr; 2017 Nov; 43(1):103. PubMed ID: 29149854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atenolol Versus Propranolol for Treatment of Infantile Hemangiomas During the Proliferative Phase: A Retrospective Noninferiority Study.
    Bayart CB; Tamburro JE; Vidimos AT; Wang L; Golden AB
    Pediatr Dermatol; 2017 Jul; 34(4):413-421. PubMed ID: 28556385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta blocker treatment for infantile hemangiomas.
    Rouhana HF; Fruge JH; Massengale WT
    Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of multifocal intracerebral and spinal hemangiomas with propranolol.
    Miquel J; Bruneau B; Dupuy A
    J Am Acad Dermatol; 2014 Apr; 70(4):e83-e84. PubMed ID: 24629368
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of propranolol in the management of periocular hemangiomas.
    Mishra A; Holmes WJM; Gorst C; Liew SH
    Plast Reconstr Surg; 2010 Aug; 126(2):671. PubMed ID: 20679854
    [No Abstract]   [Full Text] [Related]  

  • 10. Atenolol use for infantile hemangiomas.
    Ballona R; Velásquez' F; Kikushima I; Zevallos JP; Nuñez J; Apagüeño C
    Indian J Dermatol Venereol Leprol; 2021; 87(2):321. PubMed ID: 33769740
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants.
    de Graaf M; Breur JMPJ; Raphaël MF; Vos M; Breugem CC; Pasmans SGMA
    J Am Acad Dermatol; 2011 Aug; 65(2):320-327. PubMed ID: 21601311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How should propranolol be initiated for infantile hemangiomas: inpatient versus outpatient?
    Patel NJ; Bauman NM
    Laryngoscope; 2014 Jun; 124(6):1279-81. PubMed ID: 24347141
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.
    El Hachem M; Gesualdo F; Diociaiuti A; Berti I; Vercellino N; Boccaletti V; Neri I; Porcedda G; Greco A; Carnevale C; Oranges T; Cutrone M; Dalmonte P
    Ital J Pediatr; 2017 Apr; 43(1):40. PubMed ID: 28424095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemangiomas in childhood].
    Schöni MH; Kernland Lang K
    Praxis (Bern 1994); 2011 May; 100(10):575-82, quiz 583-4. PubMed ID: 21563093
    [No Abstract]   [Full Text] [Related]  

  • 15. Delayed-onset of multiple cutaneous infantile hemangiomas due to propranolol: a case report.
    Porcel Chacón R; del Boz González J; Navarro Morón J
    Pediatrics; 2015 Apr; 135(4):e1064-6. PubMed ID: 25780066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infantile hepatic hemangiomas: first-line propranolol monotherapy as new treatment strategy?].
    Baranowski S; Winkler A; Kunzi-Rapp K; Schaal M; Hempel S; Debatin KM; Posovszky C
    Klin Padiatr; 2012 Oct; 224(6):393-5. PubMed ID: 23143767
    [No Abstract]   [Full Text] [Related]  

  • 17. [Infantile hemangioma and propranolol: a therapeutic "revolution". Literature review].
    Yilmaz L; Dangoisse C; Semaille P
    Rev Med Brux; 2013; 34(6):479-84. PubMed ID: 24505868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol in the management of airway infantile hemangiomas.
    Rosbe KW; Suh KY; Meyer AK; Maguiness SM; Frieden IJ
    Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):658-65. PubMed ID: 20644059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient Perspectives: Propranolol for infantile hemangiomas.
    Pediatr Dermatol; 2016 Sep; 33(5):549-50. PubMed ID: 27595871
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis and management of infantile hemangiomas.
    Püttgen KB
    Pediatr Clin North Am; 2014 Apr; 61(2):383-402. PubMed ID: 24636652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.